Literature DB >> 15518811

Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.

Hongmei Mo1, Alex K Konstantinidis, Kent D Stewart, Tatyana Dekhtyar, Teresa Ng, Kerry Swift, Edmund D Matayoshi, Warren Kati, William Kohlbrenner, Akhteruzzaman Molla.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) gp41 plays an important role in mediating the fusion of HIV with host cells. During the fusion process, three N-terminal helices and three C-terminal helices pack in an anti-parallel direction to form a six-helix bundle. X-ray crystallographic analysis of the gp41 core demonstrated that within each coiled-coil interface, there is a deep and large pocket, formed by a cluster of residues in the N-helix coiled-coil. In this report, we systematically analyzed the role of seven conserved residues that are either lining or packing this pocket on the infectivity and interhelical interaction using novel approaches. Our results show that residues L568, V570, W571, and K574 of the N-helix that are lining the side chain and right wall of the pocket are important for establishing a productive infection. Mutations V570A and W571A completely abolished replication, while replication of the L568A and K574A mutants was significantly attenuated relative to wild type. Similarly, residues W628, W631, and I635 of the C-helix that insert into the pocket are essential for infectivity. The impaired infectivity of these seven mutants is in part attributed to the loss in binding affinity of the interhelical interaction. Molecular modeling of the crystal structure of the coiled-coil further shows that alanine substitution of those residues disrupts the hydrophobic interaction between the N- and C-helix. These results suggest that the conserved residues in the coiled-coil domain play a key role in HIV infection and this coiled-coil pocket is a good target for development of inhibitors against HIV. In addition, our data indicate that the novel fluorescence polarization assay described in this study could be valuable in screening for inhibitors that block the interhelical interaction and HIV entry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518811     DOI: 10.1016/j.virol.2004.08.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.

Authors:  Huihui Chong; Xue Yao; Zonglin Qiu; Bo Qin; Ruiyun Han; Sandro Waltersperger; Meitian Wang; Sheng Cui; Yuxian He
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

2.  A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41.

Authors:  Miriam Gochin; Ryan Savage; Spencer Hinckley; Lifeng Cai
Journal:  Biol Chem       Date:  2006-04       Impact factor: 3.915

3.  A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.

Authors:  Lifeng Cai; Miriam Gochin
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

4.  A suite of modular fluorescence assays interrogate the human immunodeficiency virus glycoprotein-41 coiled coil and assist in determining binding mechanism of low molecular weight fusion inhibitors.

Authors:  Miriam Gochin
Journal:  Assay Drug Dev Technol       Date:  2012-08-16       Impact factor: 1.738

5.  Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity.

Authors:  John Pietzsch; Johannes F Scheid; Hugo Mouquet; Michael S Seaman; Christopher C Broder; Michel C Nussenzweig
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 6.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

7.  Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition.

Authors:  Yuxian He; Shuwen Liu; Jingjing Li; Hong Lu; Zhi Qi; Zhonghua Liu; Asim K Debnath; Shibo Jiang
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.

Authors:  Miriam Gochin; Lifeng Cai
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

Review 9.  Peptides in the treatment of AIDS.

Authors:  Fred Naider; Jacob Anglister
Journal:  Curr Opin Struct Biol       Date:  2009-07-23       Impact factor: 6.809

10.  Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.

Authors:  R C Zahn; F G Hermann; E-Y Kim; M D Rett; S M Wolinsky; R P Johnson; F Villinger; D von Laer; J E Schmitz
Journal:  Gene Ther       Date:  2008-05-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.